CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 18  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1093
LYS 10.0763
GLU 20.0359
LEU 30.0195
ARG 40.0290
CYS 50.0260
GLN 60.0167
CYS 70.0078
ILE 80.0056
LYS 90.0034
THR 100.0064
TYR 110.0041
SER 120.0122
LYS 130.0257
PRO 140.0096
PHE 150.0075
HIS 160.0180
PRO 170.0119
LYS 180.0214
PHE 190.0206
ILE 200.0143
LYS 210.0191
GLU 220.0145
LEU 230.0133
ARG 240.0118
VAL 250.0112
ILE 260.0166
GLU 270.0199
SER 280.0223
GLY 290.0180
PRO 300.0257
HIS 310.0183
CYS 320.0223
ALA 330.0301
ASN 340.0199
THR 350.0189
GLU 360.0150
ILE 370.0071
ILE 380.0067
VAL 390.0077
LYS 400.0131
LEU 410.0194
SER 420.0293
ASP 430.0392
GLY 440.0310
ARG 450.0281
GLU 460.0154
LEU 470.0053
CYS 480.0043
LEU 490.0063
ASP 500.0116
PRO 510.0077
LYS 520.0256
GLU 530.0073
ASN 540.0171
TRP 550.0132
VAL 560.0081
GLN 570.0184
ARG 580.0184
VAL 590.0114
VAL 600.0118
GLU 610.0224
LYS 620.0123
PHE 630.0086
LEU 640.0078
LYS 650.0224
ARG 660.0252
ALA 670.0321
GLU 680.0395
ASN 690.1093

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.